Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-02-28 @ 7:10 AM
Study NCT ID:
NCT00516360
Status:
UNKNOWN
Last Update Posted:
2008-05-30
First Post:
2007-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
T32AI007464
Study Type:
NIH
Study Domain:
None
Study Link:
https://reporter.nih.gov/quickSearch/T32AI007464
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Erik Thingvoll, MD
Old Organization:
University of Rochester Medical Center
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |